Verona Pharma (VRNA) Competitor Comparison
We are evaluating the key criteria listed to compare Verona Pharma (VRNA) against its competitors in the Biotechnology industry.
Market Capitalization
101 / 368Gross Profits
146 / 278Total Revenue
253 / 300EBITDA
153 / 337Free Cashflow
181 / 352Quick Ratio
11 / 357Earnings per Share
207 / 359Dividend yield
0 / 6Total Cash
126 / 358Performance 3 years
8 / 368Performance 5 years
12 / 368Performance 10 years
46 / 368Linearity 3 years
364 / 368Linearity 5 years
363 / 368Linearity 10 years
344 / 368Total Rank
56 / 368Dividend Rank
302 / 368Valuation Rank
109 / 368Piotroski Rank
105 / 368Muliplier Rank
229 / 368Muliplier Rank - VRNA ranking 229 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.